RU95106997A - Medicinal agent for treatment of infectious disease in animals and methods of treatment of infectious disease in animals - Google Patents

Medicinal agent for treatment of infectious disease in animals and methods of treatment of infectious disease in animals

Info

Publication number
RU95106997A
RU95106997A RU95106997/13A RU95106997A RU95106997A RU 95106997 A RU95106997 A RU 95106997A RU 95106997/13 A RU95106997/13 A RU 95106997/13A RU 95106997 A RU95106997 A RU 95106997A RU 95106997 A RU95106997 A RU 95106997A
Authority
RU
Russia
Prior art keywords
animals
treatment
nitrofuran
sulfate
following ratio
Prior art date
Application number
RU95106997/13A
Other languages
Russian (ru)
Other versions
RU2103997C1 (en
Inventor
С.Б. Кравченко
И.Б. Волков
А.К. Кравченко
Original Assignee
Акционерное общество закрытого типа "Гекта"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное общество закрытого типа "Гекта" filed Critical Акционерное общество закрытого типа "Гекта"
Priority to RU95106997A priority Critical patent/RU2103997C1/en
Publication of RU95106997A publication Critical patent/RU95106997A/en
Application granted granted Critical
Publication of RU2103997C1 publication Critical patent/RU2103997C1/en

Links

Abstract

FIELD: veterinary science. SUBSTANCE: agent can be prepared as composition at the following ratio of components, wt.-%: nitrofuran 0.5-2.5; polymixin M sulfate 0.35-0.95; native aubasidan 17.5-22.5; nipagin 0.1-0.15; citric acid 1.0-1.2; sodium hydroxide 0.3-0.35, and water - the rest. Medicinal agent can be used for treatment of gastroenteric disease in animals at the following ratio of active components, wt.-%: nitrofuran 1.0, and polymixin M sulfate 0.8. Preferable doses (at oral administration) - 0.5-1 ml/kg animal mass, 2 times per a day, for 3-5 days. Medicinal agent can be used for treatment of gynecological sickness in cows at the following ratio of active components, wt.-%: nitrofuran 2.0, and polymixin M sulfate 0.5. Preferable doses (at intrauterine administration) - 200-300 ml for one dose, treatment course - 2-4 doses. EFFECT: enhanced therapeutic effectiveness, broad spectrum of curative action.

Claims (1)

Предлагается лекарственное средство для лечения инфекционных заболеваний животных и способы лечения инфекционных заболеваний животных. Изобретение относится к ветеринарии, а именно к лекарственным препаратам, используемым для лечения инфекционных заболеваний. Предлагаемое лекарственное средство обладает широкой областью применения и спектром лечебного действия, а также повышенной терапевтической эффективностью и может быть приготовлено в форме композиции при следующем соотношении компонентов: нитрофуран 0,5 - 2,5, полимиксина М сульфат 0,35 - 0,95, аубазидан нативный 17,5 - 22,5, нипагин 0,1 - 0,15, кислота лимонная 1,0 - 1,2, натр едкий 0,3 - 0,35, вода остальное. Лекарственное средство может быть использовано для лечения желудочно-кишечных заболеваний животных при следующем соотношении активных компонентов: нитрофуран 1,0, полимиксина М сульфат 0,8. При этом предпочтительными являются (при пероральном введении) дозы 0,5 - 1мл/кг массы животного 2 раза в день в течение 3 - 5 дней. Лекарственное средство может быть использовано для лечения гинекологических заболеваний коров при следующем соотношении активных компонентов: нитрофуран 2,0, полимиксина М сульфат 0,5. При этом предпочтительными являются (при внутриматочном введении) дозы 200 - 300 мл на одно введение, курс лечения 2 - 4 введения.A medicament for treating infectious diseases of animals and methods for treating infectious diseases of animals are provided. The invention relates to veterinary medicine, in particular to drugs used to treat infectious diseases. The proposed drug has a wide range of applications and a range of therapeutic effects, as well as increased therapeutic efficacy and can be prepared in the form of a composition with the following ratio of components: nitrofuran 0.5 - 2.5, polymyxin M sulfate 0.35 - 0.95, aubazidan native 17.5 - 22.5, nipagin 0.1 - 0.15, citric acid 1.0 - 1.2, caustic soda 0.3 - 0.35, the rest is water. The drug can be used to treat gastrointestinal diseases of animals in the following ratio of active components: nitrofuran 1.0, polymyxin M sulfate 0.8. In this case, preferred are (when administered orally) doses of 0.5-1 ml / kg of animal weight 2 times a day for 3 to 5 days. The drug can be used to treat gynecological diseases of cows in the following ratio of active components: nitrofuran 2.0, polymyxin M sulfate 0.5. In this case, preferred are (with intrauterine administration) doses of 200 to 300 ml per administration, the course of treatment is 2 to 4 administrations.
RU95106997A 1995-04-19 1995-04-19 Medicinal agent for treatment of animal disease of bacterial etiology, method of treatment of animal gastroenteric disease of bacterial etiology and methods of treatment of gynecological disease of bacterial etiology in animals RU2103997C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU95106997A RU2103997C1 (en) 1995-04-19 1995-04-19 Medicinal agent for treatment of animal disease of bacterial etiology, method of treatment of animal gastroenteric disease of bacterial etiology and methods of treatment of gynecological disease of bacterial etiology in animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU95106997A RU2103997C1 (en) 1995-04-19 1995-04-19 Medicinal agent for treatment of animal disease of bacterial etiology, method of treatment of animal gastroenteric disease of bacterial etiology and methods of treatment of gynecological disease of bacterial etiology in animals

Publications (2)

Publication Number Publication Date
RU95106997A true RU95106997A (en) 1997-02-20
RU2103997C1 RU2103997C1 (en) 1998-02-10

Family

ID=20167313

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95106997A RU2103997C1 (en) 1995-04-19 1995-04-19 Medicinal agent for treatment of animal disease of bacterial etiology, method of treatment of animal gastroenteric disease of bacterial etiology and methods of treatment of gynecological disease of bacterial etiology in animals

Country Status (1)

Country Link
RU (1) RU2103997C1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018069804A2 (en) * 2016-10-10 2018-04-19 Przedsiebiorstwo Produkcji Farmaceutycznej Hasco-Lek S.A. New furazidin compositions and methods of their manufacture
PL236891B1 (en) * 2017-06-21 2021-02-22 Aflofarm Farm Polska Spolka Z Ograniczona Odpowiedzialnoscia Fluid form of furagin administering and method for obtaining it

Also Published As

Publication number Publication date
RU2103997C1 (en) 1998-02-10

Similar Documents

Publication Publication Date Title
RU95107881A (en) Pharmaceutical composition for allergic disease treatment, method of antihistamine treatment, use of composition for medicinal preparation preparing
BRPI0506705A (en) composed of azabenzofuran-substituted thioureas, pharmaceutical compositions and their uses
RU2008119454A (en) MEDICINE FOR PROTECTION OF MOTOR NEURON IN PATIENTS WITH LATERAL AMYOTROPHIC SCLEROSIS
US8178498B1 (en) Medicament and method of treating an organism with medicaments
RU2008110933A (en) APPLICATION OF AMBROXOL FOR TREATMENT OF RINOVIRAL INFECTIONS
RU95101385A (en) Products containing g-csf and tnf-binding protein
US4469702A (en) Analgesic composition and use thereof to ameliorate deep and intractable pain
ES2175663T3 (en) SOLID PHARMACEUTICAL COMPOSITIONS CONTAINING MILTEPHOSINE FOR ORAL ADMINISTRATION IN THE TREATMENT OF LESHMANIASIS.
WO1991002529A2 (en) Product and method for killing abnormal vertebrate cells
US3928578A (en) Composition for control of white muscle disease
RU95106997A (en) Medicinal agent for treatment of infectious disease in animals and methods of treatment of infectious disease in animals
US4474759A (en) Method of treating bacterial, viral or parasitic diseases
US5100653A (en) Topical compositions for treating mouth tissues
RU95107063A (en) Medicinal agent for treatment of infectious disease in animals and methods of treatment of infectious disease in animals
US20060287364A1 (en) Methods of prevention of infection with HIV/AIDS, venereal disease and influenza
KR100227125B1 (en) Use of benzimidazole anthelmintic in the treatment of microsporidial infections
RU2107502C1 (en) Iodine monochloride, veterinary preparation possessing wide range of action
KR920700626A (en) Drugs for the treatment of toxoplasma disease
KR20010041489A (en) Fungicide Composition Comprising a Benzoylphenylurea
CA2438164A1 (en) Use of preparations containing selenite or selenate
RU2426531C1 (en) Liquid water pharmaceutical composition of ambroxol and pharmaceutical preparation based on it, intended for treating diseases of respiratory ways with formation of viscous sputum (versions)
US3074848A (en) 2-hydroxy-5,2'-dichloro-4'-nitrobenzanilide for combating tapeworms
SU858831A1 (en) Method of treating horned cattle ill by cysticercosis
KR830008678A (en) Analgesic composition
US3423508A (en) Method of combatting herpes virus with 5-nitrouracil

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20040420